{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:41Z","timestamp":1786118861095,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K02169"],"award-info":[{"award-number":["JP24K02169"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K06494"],"award-info":[{"award-number":["JP21K06494"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004721","name":"University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0325032"],"award-info":[{"award-number":["JP21wm0325032"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jmb.2026.169914","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:18:30Z","timestamp":1782170310000},"page":"169914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allosteric Targeting of the ACE2 Dimer Interface by a Medium-sized Compound Inhibits SARS-CoV-2 Entry"],"prefix":"10.1016","volume":"438","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-7112","authenticated-orcid":false,"given":"Mariko","family":"Yokogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunki","family":"Kaneichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahoro","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiga","family":"Otake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3647-7973","authenticated-orcid":false,"given":"Yugo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-1806","authenticated-orcid":false,"given":"Yuichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-7259","authenticated-orcid":false,"given":"Yoshimi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-0807","authenticated-orcid":false,"given":"Kohji","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0702-0691","authenticated-orcid":false,"given":"Masayoshi","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Ikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-4316","authenticated-orcid":false,"given":"Masanori","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2026.169914_b0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000507423","article-title":"COVID-19 outbreak: an overview","volume":"64","author":"Ciotti","year":"2019","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jmb.2026.169914_b0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3103\/S0891416820020044","article-title":"The new coronavirus COVID-19 infection","volume":"35","author":"Bevova","year":"2020","journal-title":"Mol. Gen. Microbiol. Virol."},{"key":"10.1016\/j.jmb.2026.169914_b0015","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2174\/1568026620999200511094117","article-title":"Epidemiological features of the 2019 novel coronavirus outbreak in China","volume":"20","author":"Qi","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jmb.2026.169914_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12929-022-00852-9","article-title":"A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies","volume":"29","author":"Kumari","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jmb.2026.169914_b0025","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1007\/s12033-024-01240-4","article-title":"Prospects of innovative therapeutics in combating the COVID-19 pandemic","volume":"67","author":"Mahendran","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.jmb.2026.169914_b0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2026.169914_b0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2026.169914_b0040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169914_b0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169914_b0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nature Microbiol."},{"key":"10.1016\/j.jmb.2026.169914_b0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169914_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2026.169914_b0065","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2026.169914_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/307315","article-title":"Angiotensin-converting enzyme 2: the first decade","volume":"2012","author":"Clarke","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.jmb.2026.169914_b0075","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2026.169914_b0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41422-021-00490-0","article-title":"Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2","volume":"31","author":"Yan","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jmb.2026.169914_b0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41421-022-00488-x","article-title":"Structures of ACE2-SIT1 recognized by Omicron variants of SARS-CoV-2","volume":"8","author":"Shen","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.jmb.2026.169914_b0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/17460441.2017.1264385","article-title":"Drug discovery beyond the rule of 5 \u2013 opportunities and challenges","volume":"12","author":"Doak","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jmb.2026.169914_b0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cbpa.2018.06.004","article-title":"Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area","volume":"44","author":"Ran","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jmb.2026.169914_b0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nature Rev. Drug Discov."},{"key":"10.1016\/j.jmb.2026.169914_b0105","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1038\/s41598-021-86616-1","article-title":"Identification of novel inhibitors of Keap1\/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning","volume":"11","author":"Shimizu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2026.169914_b0110","article-title":"DLiP-PPI library: an integrated chemical database of small-to-medium-sized molecules targeting protein-protein interactions","volume":"10","author":"Ikeda","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.jmb.2026.169914_b0115","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1039\/D3CC01283B","article-title":"Applying deep learning to iterative screening of medium-sized molecules for protein-protein interaction-targeted drug discovery","volume":"59","author":"Shimizu","year":"2023","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.jmb.2026.169914_b0120","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nature Rev. Microbiol."},{"key":"10.1016\/j.jmb.2026.169914_b0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1165\/rcmb.2020-0322PS","article-title":"Targeting ACE2 for COVID-19 therapy: opportunities and challenges","volume":"64","author":"Jia","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jmb.2026.169914_b0130","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10439-022-03094-w","article-title":"Advances in targeting ACE2 for developing COVID-19 therapeutics","volume":"50","author":"Suvarnapathaki","year":"2022","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.jmb.2026.169914_b0135","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cell.2023.01.039","article-title":"Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic","volume":"186","author":"Oudit","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169914_b0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00705-025-06327-0","article-title":"ACE2, a therapeutic target of COVID-19, needs to be treated with caution","volume":"170","author":"Liu","year":"2025","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jmb.2026.169914_b0145","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/s41467-024-48921-x","article-title":"Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2","volume":"15","author":"Li","year":"2024","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2026.169914_b0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41589-022-01149-6","article-title":"Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection","volume":"19","author":"Oh","year":"2023","journal-title":"Nature Chem. Biol."},{"key":"10.1016\/j.jmb.2026.169914_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2022.916700","article-title":"Disrupting ACE2 dimerization mitigates the infection by SARS-CoV-2 pseudovirus","volume":"2","author":"Zhu","year":"2022","journal-title":"Front Virol."},{"key":"10.1016\/j.jmb.2026.169914_b0160","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400973","article-title":"Peptides corresponding to the receptor-binding domain (RBD) of several SARS-CoV-2 variants of concern prevent recognition of the human ACE2 receptor and consecutive cell infections","author":"Schwarze","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmb.2026.169914_b0165","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.cell.2025.02.004","article-title":"Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover risk","volume":"188","author":"Jiang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169914_b0170","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.cell.2024.12.031","article-title":"Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses","volume":"188","author":"Ma","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169914_b0175","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.cell.2024.12.032","article-title":"Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses","volume":"188","author":"Park","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169914_b0180","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2025.01.042","article-title":"Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor","volume":"188","author":"Chen","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169914_b0185","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.immuni.2021.06.015","article-title":"Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants","volume":"54","author":"Moriyama","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jmb.2026.169914_b0190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2022.01.106","article-title":"The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione","volume":"597","author":"Murae","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2026.169914_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109363","article-title":"Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies","volume":"27","author":"Inoue","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jmb.2026.169914_b0200","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2026.169914_b0205","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.1021\/jacs.1c03945","article-title":"NMR based SARS-CoV-2 antibody screening","volume":"143","author":"Schoenle","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2026.169914_b0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-42404-3","article-title":"Glycan-binding properties of SARS-CoV-2 spike proteins: interactions with aminoglycoside antibiotics","volume":"16","author":"Hatakeyama","year":"2026","journal-title":"Sci. Rep."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283626002871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283626002871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:57:03Z","timestamp":1786035423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283626002871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0022283626002871"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2026.169914","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allosteric Targeting of the ACE2 Dimer Interface by a Medium-sized Compound Inhibits SARS-CoV-2 Entry","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2026.169914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"169914"}}